Los Angeles Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $78.8K | Hold |
871
| – | – | ﹤0.01% | 1398 |
|
|
2025
Q4 | $86.7K | Buy |
+871
| New | +$82.6K | ﹤0.01% | 1445 |
|
|
2021
Q4 | – | Sell |
-3,193
| Closed | -$454K | – | 1510 |
|
|
2021
Q3 | $454K | Sell |
3,193
-37,489
| -92% | -$5.51M | ﹤0.01% | 1098 |
|
|
2021
Q2 | $6.35M | Sell |
40,682
-19,518
| -32% | -$3.16M | 0.03% | 358 |
|
|
2021
Q1 | $9.36M | Sell |
60,200
-39,061
| -39% | -$6.05M | 0.04% | 317 |
|
|
2020
Q4 | $14.8M | Buy |
99,261
+10,605
| +12% | +$1.5M | 0.06% | 219 |
|
|
2020
Q3 | $11.7M | Buy |
88,656
+6,425
| +8% | +$839K | 0.05% | 227 |
|
|
2020
Q2 | $9.53M | Buy |
82,231
+9,600
| +13% | +$1.11M | 0.05% | 281 |
|
|
2020
Q1 | $7.13M | Buy |
72,631
+319
| +0.4% | +$41.8K | 0.05% | 284 |
|
|
2019
Q4 | $10.5M | Buy |
72,312
+15,743
| +28% | +$2.17M | 0.05% | 277 |
|
|
2019
Q3 | $7.54M | Buy |
56,569
+50,439
| +823% | +$6.52M | 0.04% | 328 |
|
|
2019
Q2 | $701K | Sell |
6,130
-10,016
| -62% | -$1.17M | ﹤0.01% | 953 |
|
|
2019
Q1 | $2M | Buy |
16,146
+4,491
| +39% | +$510K | 0.01% | 654 |
|
|
2018
Q4 | $1.17M | Buy |
11,655
+246
| +2% | +$27.7K | 0.01% | 683 |
|
|
2018
Q3 | $1.46M | Buy |
+11,409
| New | +$1.36M | 0.01% | 754 |
|
|
2018
Q1 | – | Sell |
-3,854
| Closed | -$452K | – | 1427 |
|
|
2017
Q4 | $452K | Sell |
3,854
-6,932
| -64% | -$784K | ﹤0.01% | 1078 |
|
|
2017
Q3 | $1.23M | Buy |
10,786
+546
| +5% | +$63K | 0.01% | 755 |
|
|
2017
Q2 | $1.28M | Buy |
10,240
+5,109
| +100% | +$606K | 0.01% | 703 |
|
|
2017
Q1 | $608K | Sell |
5,131
-1,137
| -18% | -$129K | ﹤0.01% | 846 |
|
|
2016
Q4 | $628K | Buy |
6,268
+2,230
| +55% | +$239K | ﹤0.01% | 818 |
|
|
2016
Q3 | $510K | Sell |
4,038
-2,091
| -34% | -$258K | ﹤0.01% | 903 |
|
|
2016
Q2 | $716K | Buy |
+6,129
| New | +$694K | 0.01% | 808 |
|
|
2015
Q4 | – | Sell |
-13,722
| Closed | -$1.25M | – | 1181 |
|
|
2015
Q3 | $1.25M | Sell |
13,722
-906
| -6% | -$90.8K | 0.01% | 635 |
|
|
2015
Q2 | $1.55M | Buy |
14,628
+906
| +7% | +$100K | 0.01% | 628 |
|
|
2015
Q1 | $1.57M | Buy |
13,722
+337
| +3% | +$38.5K | 0.01% | 621 |
|
|
2014
Q4 | $1.47M | Buy |
13,385
+139
| +1% | +$14.7K | 0.01% | 558 |
|
|
2014
Q3 | $1.29M | Sell |
13,246
-5,029
| -28% | -$495K | 0.02% | 544 |
|
|
2014
Q2 | $1.84M | Buy |
18,275
+5,132
| +39% | +$501K | 0.02% | 518 |
|
|
2014
Q1 | $1.21M | Hold |
13,143
| – | – | 0.01% | 616 |
|
|
2013
Q4 | $1.19M | Hold |
13,143
| – | – | 0.01% | 635 |
|
|
2013
Q3 | $1.05M | Hold |
13,143
| – | – | 0.01% | 655 |
|
|
2013
Q2 | $956K | Buy |
+13,143
| New | +$983K | 0.01% | 671 |
|
Other funds holding ZBH
VCM
VPM
Los Angeles Capital Management's ZBH Position: Q1 2026 in Review
Los Angeles Capital Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 871 shares worth $78.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.
Los Angeles Capital Management first reported a position in ZBH in Q2 2013 and has held it in 32 quarters since. The position peaked at $14.8M in Q4 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Los Angeles Capital Management held 871 shares of Zimmer Biomet worth $78.8K as of Q1 2026.
- Los Angeles Capital Management left its Zimmer Biomet share count unchanged in Q1 2026.
- Zimmer Biomet made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1398 holding.
- Los Angeles Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 32 quarters since.
- Los Angeles Capital Management's Zimmer Biomet position peaked at $14.8M in Q4 2020.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.